Table 2 Effect ovarian cancer ascites OVC346 and OVC509 on TRAIL IC50 in primary samples of ovarian cancer cells
Primary samples | ascites OVC346 | ascites OVC509 | ||
|---|---|---|---|---|
ascites | - | + | - | + |
218A | 7.2 ± 1.3 | 12 ± 1.1 | 7 ± 0.7 | 14.5 ± 0.8 |
231A | 4.8 ± 0.7 | 5.5 ± 0.7 | 4.4 ± 0.8 | 7.5 ± 0.6 |
238A | 16 ± 1.8 | 19.5 ± 0.9 | 15 ± 0.4 | > 30 |
285A | 12 ± 2.1 | 18.8 ± 1.4 | 14 ± 1.1 | > 30 |
318A | 5.5 ± 0.5 | 7.5 ± 0.7 | 5.7 ± 0.6 | 12 ± 0.9 |
327A | 5.3 ± 0.7 | 7.5 ± 0.5 | 5.2 ± 0.7 | 9.7 ± 0.8 |
339A | 7.8 ± 1.1 | 14.5 ± 0.7 | 7.5 ± 1.2 | 19.5 ± 0.6 |
341T | 10.8 ± 1.3 | 16.5 ± 1.2 | 10 ± 0.4 | 19.5 ± 0.9 |
346A | 6.5 ± 0.9 | 9.2 ± 0.6 | 6.5 ± 0.6 | 16 ± 1 |